Neurogesx loses financial expert from its audit committee
Bruce Peacock resigned today from the board of directors after serving less than two years there, where he also chaired its audit committee and was deemed its "financial expert" Read More → 
What's next in tech
Bruce Peacock resigned today from the board of directors after serving less than two years there, where he also chaired its audit committee and was deemed its "financial expert" Read More → 
NeurogesX said Thursday that the European Medicines Agency's committee for medicinal products for human use has recommended approval of Qutenza, the San Mateo biopharmaceutical's treatment of peripheral neuropathic pain Read More → 